Advicenne 2017 Financial Results and Operational Perspectives for 2018

April 10, 2018

Nîmes, France, April 10th, 2017 – Advicenne (Euronext : ADVIC), a specialist pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal diseases, published its financial results for 2017 and confirmed its operational perspectives for 2018.